Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF497 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | TXNDC16 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | LEF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | THAP8 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | KIAA1958 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | KCNB2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
mRNA | SHCBP1 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | FUZ | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | ST8SIA3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | CTD-3105H18.18 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |